Ponezumab is under investigation in clinical trial NCT00607308 (A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease).
货号（Catalog No.）
CSD00252
通用名INN
Ponezumab
纯度(Purity)
>95%
浓度( Concentration)
1mg/ml
Formulation
PBS buffer pH7.5
Source
CHO cells
内毒素(Endotoxin level)
Please contact with the lab for this information.
生物活性
产品描述(Description)
Ponezumab is under investigation in clinical trial NCT00607308 (A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease).
别名(Alternative names)
PF-04360365,RN-1219,clone 9TL
靶点;物种(Specificity target name;species)
APP Abeta40[Homo sapiens]
种类(Species)
Humanized
受体鉴定(Receptor identification)
IgG2-kappa
化学信息
CAS
1178862-65-1
存储条件(Storage)
store at -80°C